ThomasL.PittsMD

Endocrinology • Chicago, IL

Diabetes, Lipid Metabolism

Associate Professor in Clinical Medicine-Endocrinology, Northwestern University Medical School

Join to view full profile

Dr. Pitts is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Pitts' full profile

Already have an account?

Office
233 E Erie St
Ste 702
Chicago, IL 60611
Phone+1 312-763-2211

Fax+1 312-763-2210
Is this information wrong?

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1981
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1976 - 1980
Northwestern University The Feinberg School of MedicineClass of 1976
Talladega CollegeB.S., Biological Sciences
Harvard UniversityA.M., Biological Chemistry

Certifications & Licensure

IL State Medical License 1977 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Physician of the Year Provident Cook County Hospital, 2011
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
Man of the Year in Medicine Alpha Kappa Alpha, 1998

Publications & Presentations

PubMed

26 citations
Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;Plos Genetics. 2012 Aug 1

Journal Articles

Changes in albumin excretion in the diabetes prevention program
Diabetes Prevention Program Research Group, Diabetes Care, 1/1/2009
Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions
Ratner,R. E., Chitson,P. A., Metzger,B. E., Dabelea,D., Bennett,P. H., Pi-Sunyer,X., Fowler,S., Kahn,S. E., Diabetes Prevention Program Research Group, J Clin Endocrinol Metab, 1/1/2008
Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program
Walker,E. A., Molitch,M., Kramer,M. K., Kahn,S., Ma,Y., Edelstein,S., Smith,K., Johnson,M. K., Kitabchi,A., Crandall,J., Diabetes Care, 1/1/2006
The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program
Carnethon,M. R., Prineas,R. J., Temprosa,M., Zhang,Z. M., Uwaifo,G., Molitch,M. E., Diabetes Prevention Program Research Group, Diabetes Care, 1/1/2006
Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program
Diabetes Prevention Program Research Group, Diabetes Care, 1/1/2005
The diabetes prevention program and its global implications
Molitch,M., Fujimoto,W., Hamman,R., Knowler,W., J Am Soc Nephrol, 1/1/2003
Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program
Diabetes Prevention Program Research Group, Diabetes Care, 1/1/2003
Reduction of the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
Pitts TL Jr, NEJM, 1/1/2002
Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance
Diabetes Prevention Program Research Group, Hypertension, 1/1/2002
The Diabetes Prevention Program: recruitment methods and results
Rubin,R. R., Fujimoto,W. Y., Marrero,D. G., Brenneman,T., Charleston,J. B., Edelstein,S. L., Fisher,E. B., Jordan,R., Knowler,W. C., Lichterman,L. C., Prince,M., Rowe,..., Control Clin Trials, 1/1/2002
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
Knowler,W. C., Barrett-Connor,E., Fowler,S. E., Hamman,R. F., Lachin,J. M., Walker,E. A., Nathan,D. M., Diabetes Prevention Program Research Group, N Engl J Med, 1/1/2002
The Diabetes Prevention Program: baseline characteristics of the randomized cohort The Diabetes Prevention Program Research Group
Diabetes Prevention Program Research Group, Diabetes Care, 1/1/2002
Join now to see all